S&P 500 7718.60 -0.38%
NASDAQ 26506.99 -0.29%
TASI 11024.73 -0.40%
Oil (WTI) 91.48 +0.00%
Oil (Brent) 96.28 +0.00%
VIX 15.30 +5.30%
Gold 4476.60 +0.00%
USD/SAR 3.76 +0.02%

Stryker Corporation

SYK · Healthcare · · USD
303.13 USD
0.00 (-1.58%)
● Updated 2026-09-07 21:04 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score STRONG SELL Short-term (Swing)

34
/ 100
Technical 20
Trend & RS 30
Momentum 36
Fundamental (0%) 89
Macro 64
Liquidity 56
ComponentScoreWeight
Technical 20.0 40%
Trend & RS 30.1 20%
Momentum 36.1 20%
Fundamental 88.9 0%
Macro 64.4 15%
Liquidity 55.6 5%

Trade Setup

Entry 303.13
Stop Loss 283.43 (6.5%)
Target 1 (1:1) 322.83 (+6.5%)
Target 2 (2:1) 342.53 (+13.0%)
ATR(14) 9.85 (3.2%)
Risk per Share 19.70
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 46.8 -0.13
Momentum 36.1 -0.56
Quality 49.7 -0.01
Composite 44.2

Quality Scores

Piotroski F-Score 7 /9 — Strong
✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score 6.26 — Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Overvalued

MetricStockSectorvs Peers
P/E Ratio 31.4 22.0 +43% above
P/B Ratio 4.8 4.0 Above
Dividend Yield 1.2% 1.5% Below avg

Comparing against Healthcare median multiples.

Trading at a premium to sector peers — verify growth justifies premium.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value
162.85
vs
Market Price
303.13
Upside
-46.3%
Margin of Safety -86.1%
Stage 1 PV (5yr FCF)14,954,207,619
Terminal Value PV47,509,420,298
Total Enterprise Value62,463,627,917

Assumptions

Base FCF2,958,115,331
Growth Rate (5yr)9.4%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
19.37%
Full Kelly
9.69%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 34/100. Estimated win rate 50%, avg win 7.0%, avg loss 4.3%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG SELL

1
Bullish Signals
4
Bearish Signals
34.07
RSI(14)
-5.6465
MACD

Relative Strength (RS) WEAK RS

25
/ 99
RS Rating
O'Neil filter: <80
RS vs SPY → FLAT (-5.3% vs SPY 3M)
RS vs Sector UNDERPERFORMING (Healthcare)
RS New High No (27d since high)
Sector Outperformance -8.3% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

IndicatorValueSignal
Rsi 34.07 NEUTRAL
Macd -5.6465 BEARISH
Ma Cross 328.87 / 337.2 DEATH CROSS
Trend Short BELOW SMA50
Trend Long BELOW SMA200
Bollinger LOWER BAND
Volume 1.07x NORMAL

Key Levels

LevelPrice
52-Week High395.90
Bollinger Upper354.37
SMA(200)337.2
SMA(50)328.87
SMA(20)329.35
Current Price303.13
Bollinger Lower304.33
52-Week Low281.00
ATR(14)9.85

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION E Confidence
50%
Acc: 1.0  |  Dist: 1.0  |  Markup: 0.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-08-31 Normal 0.91x Normal bar — no special VSA pattern
2026-09-01 Normal 0.96x Normal bar — no special VSA pattern
2026-09-02 Normal 0.98x Normal bar — no special VSA pattern
2026-09-03 Normal 1.19x Normal bar — no special VSA pattern
2026-09-04 Normal 1.07x Normal bar — no special VSA pattern

Ichimoku Cloud BEARISH

LineValueStatus
Tenkan-sen (9) 317.95 Below Kijun
Kijun-sen (26) 326.14 Base line
Senkou A 322.04 Leading span A
Senkou B 327.50 Leading span B
Cloud 322.04 – 327.50 Bearish (Red)
Price vs Cloud 303.13 Below Cloud
Chikou Span 325.70 Bearish
Alignment Score 0/4 BEARISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BEARISH
BB: 304.33 – 354.37  |  KC: 315.52 – 343.18

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Hidden Bullish RSI 12

Anchored VWAP

VWAP: 318.64 Anchor: 2026-05-11 (52w Low) BELOW AVWAP -4.9%

Heikin-Ashi Trend

BEARISH Full data via /api/advanced/SYK

Valuation

MetricValue
Market Cap116.27B
P/E (TTM)31.45
Forward P/EN/A
P/B4.85
EPS9.64

Financial Health

MetricValue
Revenue Growth9.4%
Profit Margin14.4%
ROE16.5%
Debt/Equity64.39
Current Ratio2.16
Dividend Yield1.2%
Payout RatioN/A
Beta0.77

Trading Data

303.13
Open
303.13
Day High
303.13
Day Low
2.35M
Volume (1.0x avg)

Recent News (8)

Stryker (SYK) is Buying ZuriMED. Can FiberLocker Strengthen its Shoulder Portfolio?
Insider Monkey · 2026-09-04
How Much Upside Can BSX Stock's Growth Deliver?
Trefis · 2026-09-04
Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money
24/7 Wall St. · 2026-09-04
Boston Scientific's ICVT Business Gains Momentum: Can Growth Continue?
Zacks · 2026-09-04
Stryker Launches FDA-Cleared Apple Vision Pro Surgical App
Zacks · 2026-09-03
Medical Devices & Supplies - Diversified Stocks Q2 Teardown: Stryker (NYSE:SYK) Vs The Rest
StockStory · 2026-09-02
ISRG Stock: The Best House On The Block Costs The Most
Trefis · 2026-09-02
The Wide Divide Priced Into Boston Scientific Stock
Trefis · 2026-09-02

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —